Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Azacitidine in Myelofibrosis

NCT00381693 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00381693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00381693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Azacitidine in Myelofibrosis
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2006
Completion date
April 30, 2009
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloproliferative disorders, secondary myelofibrosis